As semaglutide improves insulin sensitivity over weeks and months, these barriers diminish and weight loss accelerates
2a, the cumulative incidence of composite outcomes was consistently higher in the GLP-1RA group compared to the DPP-4i group, demonstrating a statistically significant increased risk in the former, with a log-rank p value of less than 0.001
The analysis included data from 1,574 participants in treatment groups and 893 in control groups
While concerns about losartan and erectile dysfunction are understandable, current evidence does not support a direct link between losartan and increased risk of ED
By offering compounded semaglutide prescriptions through a streamlined telehealth weight loss program , patients receive expert-backed support without unnecessary delays or complications
Fortunately, there are effective alternatives